CPT® Code 90646

Deleted

The CPT® Code 90646 refers to the Hemophilus influenza b vaccine (Hib), specifically the PRP-D conjugate formulation, which is designated for booster use only and is administered via intramuscular injection. Vaccines, unlike immune globulins that offer short-term, passive immunity, are designed to provide active, long-term immunity. This is achieved by introducing altered versions of specific pathogens, such as viruses or bacteria, into the recipient's immune system. This exposure prompts the immune system to produce its own antibodies, enabling the body to "remember" how to respond effectively upon future encounters with the same antigen. Hemophilus influenza type b (Hib) is particularly concerning for children under the age of five, as it can lead to severe health complications, including pneumonia, significant swelling of the throat, infections in the joints and bones, and meningitis, which may result in lasting effects such as brain damage and hearing loss. The codes associated with Hib vaccines, including 90646, are used to report the specific conjugate vaccine administered. It is important to note that this code is distinct from others in the Hib vaccine series, such as code 90645, which covers the HbOC conjugate 4-dose schedule, code 90647, which pertains to the PRP-OMP conjugate 3-dose schedule, and code 90648, which indicates the PRP-T conjugate 4-dose schedule. Each of these codes is utilized solely to report the specific vaccine product administered.